ARCH Venture Fund X, L.P.

Related Filers (25)

Ownership (20)

4
Monday, 2/12/2024
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 11/17/2023
EQRx, Inc.: Major Shareholders
4
Wednesday, 9/20/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/14/2023
Neumora Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 2/13/2023
Prime Medicine, Inc.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Verve Therapeutics, Inc.: Major Shareholders
4
Wednesday, 10/26/2022
Prime Medicine, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/19/2022
Prime Medicine, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 2/11/2022
EQRx, Inc.: Major Shareholders
SC 13G
Thursday, 2/10/2022
Erasca, Inc.: Major Shareholders
SC 13G
Wednesday, 2/9/2022
Verve Therapeutics, Inc.: Major Shareholders
4
Tuesday, 7/20/2021
Erasca, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/15/2021
Erasca, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Verve Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/16/2021
Verve Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 2/10/2021
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/10/2021
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/3/2021
Sana Biotechnology, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 2/3/2021
Sana Biotechnology, Inc.: Initial statement of beneficial ownership of securities
Show More